Apellis Pharmaceuticals (APLS) Stock: Headed Up On Fast Track Designation

Apellis Pharmaceuticals Inc (NASDAQ: APLS) is having a great start to the trading session this morning, and for good reason. The company announced that it has received Fast Track designation from the FDA for one of its clinical candidates. As you could imagine, the news excited investors, pushing the stock on a run for the … Read more

Biotech Stock News (ATHX) (FLXN)

Athersys (NASDAQ:ATHX) In after-hours trade on February 18, 2016 shares of Athersys were up 21% after the company announced that it had obtained positive phase 2 results for its stroke trial. The phase 2 trial was broken down into two different parts. The first part was a dose selection phase of 16 patients split into … Read more